homefeedbacksupportlog on 6-Sep-2008 
  About F1000

 What is F1000 Biology?
 Key features
 How it's organized
 FAQs
 Faculties and sections
 Scope of sections
 List of Faculty Members
 The evaluation system
 Citing F1000
 Take a tour of the site
 Accessing fulltexts
 PubMed linkout
 How to subscribe
 Academic subscriptions
 Corporate subscriptions
 Try F1000 for free
 Who we are
 Media information
 Librarian resources
 Press releases
 In the press
 Developing countries
 F1000 Medicine
 Terms and conditions
 Privacy policy
 Contact us


Victor Ling
BC Cancer Research Centre, Canada

Faculty Member: Pharmacology & Drug Discovery > Cancer Therapeutics [ since 4 May 2007 ]
[ Evaluations ]
to email [Help]
Evaluations

Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer.
Sauna ZE, Kimchi-Sarfaty C, Ambudkar SV, Gottesman MM
Cancer Res 2007 Oct 15 67(20):9609-12 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Victor Ling
Evaluated 23 Jan 2008

^Top  Back to Faculty Members



© 1999-2008 Biology Reports Ltd unless otherwise stated < info@f1000.com >   Terms and conditions   Legal info